Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fergus J Couch

Showing results (251-260 of 563) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>Adriana I Apostol, Jacek Gronwald, Cezary Cybulski, et al.
Fertility and Sterility|August 3, 2019
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancerKathryn J Ruddy, Daniel J Schaid, Ann H Partridge, et al.
Breast Cancer Research and Treatment|November 3, 2018
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissuesYujing J Heng, Jun Wang, Thomas U Ahearn, et al.
Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.
American Journal of Human Genetics|September 18, 2025
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variantsMarcy E Richardson, Megan F H Bishop, Megan A Holdren, et al.
Breast Cancer Research and Treatment|November 1, 2011
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variantChristina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
JAMA Oncology|February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Pageof 57

Showing results (251-260 of 563) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>Adriana I Apostol, Jacek Gronwald, Cezary Cybulski, et al.
Fertility and Sterility|August 3, 2019
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancerKathryn J Ruddy, Daniel J Schaid, Ann H Partridge, et al.
Breast Cancer Research and Treatment|November 3, 2018
Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissuesYujing J Heng, Jun Wang, Thomas U Ahearn, et al.
Molecular Cancer|October 7, 2024
Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitorsAnnapoorna Venkatachalam, Cristina Correia, Kevin L Peterson, et al.
Biorxiv : the Preprint Server for Biology|January 3, 2024
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variantsHuaizhi Huang, Chunling Hu, Jie Na, et al.
Journal of Medical Genetics|October 12, 2012
Rare variants in XRCC2 as breast cancer susceptibility allelesFlorentine S Hilbers, Juul T Wijnen, Nicoline Hoogerbrugge, et al.
American Journal of Human Genetics|September 18, 2025
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variantsMarcy E Richardson, Megan F H Bishop, Megan A Holdren, et al.
Breast Cancer Research and Treatment|November 1, 2011
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variantChristina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
JAMA Oncology|February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Pageof 57